Results 131 to 140 of about 82,474 (317)

Relevance of ultrasound examination in general practice. A case report of a patient with autosomal dominant polycystic kidney disease

Journal of Ultrasonography, 2013
Autosomal dominant polycystic kidney disease is a genetic disorder which results in the development of multiple cysts in the kidneys and other parenchymal organs. The two genes in which mutations are known to cause autosomal dominant polycystic kidney
Izabela Cwojdzińska-Jankowska, Anna Plewa   +1 more
doaj  

Oral-facial-digital syndrome, with polycystic kidneys and liver: pathological and cytogenetic studies. [PDF]

, 1966
C C Tucker, Sara Finley, E S Tucker, W H Finley   +3 more
openalex   +1 more source

Surgical Treatment of Polycystic Kidney [PDF]

The American Journal of the Medical Sciences, 1912
n ...
openaire   +2 more sources

Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective

Diabetes, Obesity and Metabolism, EarlyView.
Abstract In India, the increasing prevalence of diabetes and obesity poses a significant threat towards a surge in the incidence of metabolic dysfunction‐associated steatotic liver disease (MASLD), formerly known as non‐alcoholic fatty liver disease (NAFLD).
Abdul Hamid Zargar, Anil Bhansali, Anirban Majumdar, Anuj Maheshwari, Arpandev Bhattacharyya, Arundhati Dasgupta, Banshi Damodarlal Saboo, Bipin Kumar Sethi, Debmalya Sanyal, Krishna G. Seshadri, Neeta Rohit Deshpande, Nitin Kapoor, Om Jitendra Lakhani, Pradeep Gopal Talwalkar, Pramila Kalra, Rabindera Nath Mehrotra, Rakesh Kumar Sahay, Rishi Shukla, Saket Kant, Sambit Das, Sanjay Chunilal Agarwal, Sanjeev Ratnakar Phatak, Shanmugasundar G., Shashank Rameshchandra Joshi, Shehla Sajid Shaikh, Sosale Ramachandra Aravind, Soumik Goswami, Sujoy Ghosh, Vijay Kumar Panikar, Viswanathan Mohan   +29 more
wiley   +1 more source

Polycystic kidney and Down Syndrome

Journal of Research in Medical Sciences, 2006
Kidney disease is not a common complication in Down Syndrome (DS). A variety of renal and urologic problems have been described in these patients and some develop renal failure. Coincidence of polycystic kidney disease and DS is a rare entity.
Azar Nickavar
doaj  

Management of delivery of a fetus with autosomal recessive polycystic kidney disease: a case report of abdominal dystocia and review of the literature

Journal of Medical Case Reports, 2019
Background Autosomal recessive renal polycystic kidney disease occurs in 1 in 20,000 live births. It is caused by mutations in both alleles of the PKHD1 gene.
Sarah Belin, Cristina Delco, Paloma Parvex, Sylviane Hanquinet, Siv Fokstuen, Begoña Martinez de Tejada, Isabelle Eperon   +6 more
doaj   +1 more source

Myotonic dystrophy and polycystic disease of the kidneys. [PDF]

, 1967
Alan E H Emery, S. Oleesky, Randy Williams   +2 more
openalex   +1 more source

Prediction of major outcomes in patients with malignant hypertension using machine learning: A report from the West Birmingham malignant hypertension registry

European Journal of Clinical Investigation, EarlyView.
Malignant hypertension (MHT) is a rare, severe condition with high morbidity and mortality. Using data from 385 patients in the West Birmingham MHT Registry, this study evaluated nine machine learning (ML) algorithms to predict a composite outcome of all‐cause mortality/dialysis over a median 11‐year follow‐up.
Antonios A. Argyris, Hironori Ishiguchi, Yang Chen, Yalin Zheng, Alena Shantsila, Eduard Shantsila, D. Gareth Beevers, Gregory Y. H. Lip   +7 more
wiley   +1 more source

Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance

Hemodialysis International, EarlyView.
ABSTRACT Introduction The cardiovascular biomarkers troponin T, N‐terminal pro‐B‐type natriuretic peptide, and fibroblast growth factor 23 are elevated in hemodialysis patients and associated with an increased cardiovascular mortality risk. Nocturnal hemodialysis improves the fluid status in hemodialysis patients.
Manouk Dam, Laura M. M. de Haan, Tiny Hoekstra, Marc Vervloet, Frans J. van Ittersum, Peter J. M. Weijs, Brigit C. van Jaarsveld   +6 more
wiley   +1 more source

Young‐onset type 2 diabetes—Epidemiology, pathophysiology, and management

Journal of Diabetes Investigation, EarlyView.
The burden of young‐onset type 2 diabetes is increasing globally, disproportionately affecting non‐White ethnic groups and low‐ and middle‐income countries. Young‐onset type 2 is more heterogeneous regarding the genetic and environmental contributions to its underlying pathophysiology, which poses challenges for glycemic management.
Andrea O.Y. Luk, Hongjiang Wu, Yingnan Fan, Baoqi Fan, Chun Kwan O, Juliana C.N. Chan   +5 more
wiley   +1 more source